Pfizer To Cooperate With Peking University Health Science Center In Quantitative Pharmacology Education
This article was originally published in PharmAsia News
Executive Summary
Pfizer China and Peking University Health Science Center will jointly establish Peking University - Pfizer quantitative pharmacology education center. According to the long-term agreement, Pfizer will set aside RMB 3 million to fund education and training of Chinese scientific talent in quantitative pharmacology, a critical technology in pharmaceutical R&D. Peking University expresses that the new center will help strengthen its capability in the domain. (Click here for more - Chinese Language)
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.